Eton Pharmaceuticals, Inc. (ETON) vs Stoke Therapeutics, Inc. (STOK)

A side-by-side comparison of Eton Pharmaceuticals, Inc. and Stoke Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ETON vs STOK

growth of $100 · dividends reinvested · last 7y
ETON +655.7% (+33.5%/yr)STOK -1.0% (-0.1%/yr)ETON compounded faster over this window
Log scale — wide-divergence pair
101001kStart $100202120232025$756$99
ETON STOK

ETON vs STOK: by the numbers

  • •STOK is the larger company ($1.56B vs $1.51B market cap).
  • •ETON is profitable (12.02% net margin) while STOK runs a net loss (-753.60%).

Metrics side by side

Valuation

MetricETONSTOK
P/E ratio143.32N/A
Forward P/E50.69N/A
P/S ratio14.3056.57
P/B ratio32.414.52
EV / EBITDA72.51N/A
FCF yield0.98%N/A

Profitability

MetricETONSTOK
Gross margin57.87%100.00%
Operating margin0.09%-11.16%
Net margin12.02%-753.60%
ROE27.24%-60.17%
ROIC20.41%-63.12%

Growth (annualized)

MetricETONSTOK
Revenue CAGR (5Y)47.98%N/A
Total return CAGR (5Y)63.04%-0.24%

Frequently asked

Is ETON or STOK more profitable?
ETON runs the higher net margin — ETON at 12.02% versus STOK at -753.60%.
How have ETON and STOK total returns compared?
Over the past 5 years, ETON delivered 63.04% and STOK delivered -0.24% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.